Microbot Medical Inc. (MBOT): Price and Financial Metrics

Microbot Medical Inc. (MBOT): $1.40

0.24 (-14.63%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

MBOT Price/Volume Stats

Current price $1.40 52-week high $5.87
Prev. close $1.64 52-week low $1.00
Day low $1.38 Volume 531,300
Day high $1.82 Avg. volume 1,427,597
50-day MA $2.21 Dividend yield N/A
200-day MA $2.56 Market Cap 16.39M

MBOT Stock Price Chart Interactive Chart >


Microbot Medical Inc. (MBOT) Company Bio


Microbot Medical Inc. operates as a medical device company. The Company specializes in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Microbot Medical offers its services in the United States.


MBOT Latest News Stream


Event/Time News Detail
Loading, please wait...

MBOT Latest Social Stream


Loading social stream, please wait...

View Full MBOT Social Stream

Latest MBOT News From Around the Web

Below are the latest news stories about MICROBOT MEDICAL INC that investors may wish to consider to help them evaluate MBOT as an investment opportunity.

Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023

The presentation follows successful extensive uses of the Company’s endovascular robotic system in pre-clinical studiesBRAINTREE, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) is honored to announce the continuous growing global recognition of its LIBERTY® Robotic Surgical System, to be presented in an abstract at the Annual Congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) on September 9, 2023. The abstract is to be present

Yahoo | September 8, 2023

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Deliver On Growth Plans?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Yahoo | August 16, 2023

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

The Agreement with a leading full turnkey manufacturer further strengthens the Company's progression towards expected first in human clinical trials followed by regulatory approval and commercializationBRAINTREE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, announces another step in its commitment to advance the commercialization processes of LIBERTY® with th

Yahoo | August 15, 2023

Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board

Professor Francois H. Cornelis is a world renown neuro interventional radiologist who specializes in minimally invasive image-guided therapiesHINGHAM, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, today announces the expansion of its global team of experts supporting the Company as scientific advisory board members ("SAB"), with Francois H. Cornelis, MD, PhD j

Yahoo | August 10, 2023

Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe

Engagement includes audit plans for ISO 13485 certification, to pave the way for obtaining CE Mark for clearance of sales in the European UnionHINGHAM, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic system, today announced the first steps towards its planned European market clearance, by engaging with a leading Notified Body. The Notified Body will audit the Company to

Yahoo | July 25, 2023

Read More 'MBOT' Stories Here

MBOT Price Returns

1-mo -32.04%
3-mo -59.18%
6-mo -39.39%
1-year -75.48%
3-year -81.46%
5-year -79.97%
YTD -53.49%
2022 -59.87%
2021 8.85%
2020 -32.25%
2019 491.28%
2018 -88.76%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!